OFS Credit Company, Inc. (OCCIO)
시가총액: 165.67M
국가: United States
산업: #Trusts_Except_Educational_Religious_and_Charitable
섹터: #Finance
홈페이지: https://www.ofscreditcompany.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2504: 10.24M / -- / -- / -- / --

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2504: -0.5 / -- / -- / -- / --

- 연간 매출(YoY%), EPS(YoY%)

#OCCIO

- 사업요약: OFS Credit Company, Inc. is a fund of OFS Advisor.

OFS Credit Company, Inc. (OCCIN)
시가총액: 165.67M
국가: United States
산업: #Trusts_Except_Educational_Religious_and_Charitable
섹터: #Finance
홈페이지: https://www.ofscreditcompany.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2504: 10.24M / -- / -- / -- / --

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2504: -0.5 / -- / -- / -- / --

- 연간 매출(YoY%), EPS(YoY%)

#OCCIN

- 사업요약: OFS Credit Company, Inc. is a fund of OFS Advisor.

Kazia Therapeutics Limited (KZIA)
시가총액: 10.94M
국가: Australia
산업: #Biotechnology_Pharmaceutical_Preparations
섹터: #Health_Care
홈페이지: https://www.kaziatherapeutics.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 22.29K / -- / -- / -- / --

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: -12.3 / -- / -- / -- / --

- 연간 매출(YoY%), EPS(YoY%)
2306: 0.0(--) / -1.123(40.5%)
2206: 0.0(-100.0%) / -1.888(-163.7%)
2106: 15.18M(--) / -0.716(58.1%)
2006: 0.0(--) / -1.707(--)

#KZIA

- 사업요약: Kazia Therapeutics Limited, together with its subsidiaries, operates as an oncology-focused biotechnology company in South Korea. Its lead development candidate is paxalisib, a small molecule, brain-penetrant inhibitor of the phosphoinositide-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway, which is in Phase 3 clinical trial, for the treatment of glioblastoma, isocitrate dehydrogenase-mutant glioma, diffuse intrinsic pontine glioma, atypical teratoid/rhabdoid tumor, brain metastases, primary central nervous system (CNS) lymphoma,...

Trio Petroleum Corp. (TPET)
시가총액: 9.4M
국가:
산업: #Oil_and_Gas_Production
섹터: #Energy
홈페이지: https://trio-petroleum.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2504: 23.27K / -- / -- / -68.1% / --
2404: 72.92K / -- / -- / -- / --
2401: 0.0 / -- / -- / -- / --
2310: 0.0 / -- / -- / -- / --
2307: 0.0 / -- / -- / -- / --

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2504: -0.22 / -- / -- / -120.0% / --
2404: -0.1 / -- / -- / 16.7% / -100.0%
2401: -0.05 / -- / -- / -41.1% / --
2310: -- / -- / -- / -- / --
2307: -0.08 / -- / -- / -- / 33.3%

- 연간 매출(YoY%), EPS(YoY%)
2310: 0.0(--) / -0.28(-70.2%)
2210: 0.0(--) / -0.164556(--)

#TPET

- 사업요약: Trio Petroleum Corp. operates as an oil and gas exploration and development company. The company's flagship project comprises the 85.775% owned working interest in the South Salinas project that consists of approximately 9,300-acre located in Monterey, California. Trio Petroleum Corp. was incorporated in 2021 and is headquartered in Bakersfield, California.

Rafael Holdings, Inc. (RFL)
시가총액: 73.51M
국가: United States
산업: #Real_Estate
섹터: #Finance
홈페이지: https://www.rafaelholdings.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2504: 362K / -- / -- / 7.7% / --
2404: 336.0K / -- / -- / 373.2% / 394.1%
2401: 68.0K / -- / -- / -- / 0.0%
2310: 68.0K / -- / -- / -- / 0.0%
2307: 68.0K / -- / -- / -- / -4.2%

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2504: -0.19 / -- / -- / 86.0% / --
2404: -1.36 / -- / -- / -2166.7% / -644.0%
2401: 0.25 / -- / -- / -- / 266.7%
2310: -0.15 / -- / -- / -- / -350.0%
2307: 0.06 / -- / -- / -- / 200.0%

- 연간 매출(YoY%), EPS(YoY%)
2307: 279000.0(-32.0%) / -0.08(98.7%)
2207: 410000.0(-48.9%) / -6.31(-323.5%)
2107: 802000.0(-83.7%) / -1.49(-125.8%)
2007: 4.91M(--) / -0.66(--)

#RFL

- 사업요약: Rafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in three segments, Healthcare, Infusion Technology, and Real Estate. The c...